172 related articles for article (PubMed ID: 33934437)
1. CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.
Shi H; Niimi A; Takeuchi T; Shiogama K; Mizutani Y; Kajino T; Inada K; Hase T; Hatta T; Shibata H; Fukui T; Chen-Yoshikawa TF; Nagano K; Murate T; Kawamoto Y; Tomida S; Takahashi T; Suzuki M
Cancer Sci; 2021 Jul; 112(7):2770-2780. PubMed ID: 33934437
[TBL] [Abstract][Full Text] [Related]
2. CERS6 required for cell migration and metastasis in lung cancer.
Suzuki M; Cao K; Kato S; Mizutani N; Tanaka K; Arima C; Tai MC; Nakatani N; Yanagisawa K; Takeuchi T; Shi H; Mizutani Y; Niimi A; Taniguchi T; Fukui T; Yokoi K; Wakahara K; Hasegawa Y; Mizutani Y; Iwaki S; Fujii S; Satou A; Tamiya-Koizumi K; Murate T; Kyogashima M; Tomida S; Takahashi T
J Cell Mol Med; 2020 Oct; 24(20):11949-11959. PubMed ID: 32902157
[TBL] [Abstract][Full Text] [Related]
3. Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
Suzuki M; Cao K; Kato S; Komizu Y; Mizutani N; Tanaka K; Arima C; Tai MC; Yanagisawa K; Togawa N; Shiraishi T; Usami N; Taniguchi T; Fukui T; Yokoi K; Wakahara K; Hasegawa Y; Mizutani Y; Igarashi Y; Inokuchi J; Iwaki S; Fujii S; Satou A; Matsumoto Y; Ueoka R; Tamiya-Koizumi K; Murate T; Nakamura M; Kyogashima M; Takahashi T
J Clin Invest; 2016 Jan; 126(1):254-65. PubMed ID: 26650179
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.
Su H; Fan G; Huang J; Qiu X
Cell Death Dis; 2022 Apr; 13(4):307. PubMed ID: 35387975
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
[TBL] [Abstract][Full Text] [Related]
6. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
7. Ceramide synthase 6 predicts the prognosis of human gastric cancer: It functions as an oncoprotein by dysregulating the SOCS2/JAK2/STAT3 pathway.
Uen YH; Fang CL; Lin CC; Hseu YC; Hung ST; Sun DP; Lin KY
Mol Carcinog; 2018 Dec; 57(12):1675-1689. PubMed ID: 30129684
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
[TBL] [Abstract][Full Text] [Related]
9. Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
Tang Y; Cao K; Wang Q; Chen J; Liu R; Wang S; Zhou J; Xie H
Oncol Rep; 2016 May; 35(5):2907-15. PubMed ID: 26934938
[TBL] [Abstract][Full Text] [Related]
10. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.
Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G
J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432
[TBL] [Abstract][Full Text] [Related]
11. Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner.
Fekry B; Esmaeilniakooshkghazi A; Krupenko SA; Krupenko NI
PLoS One; 2016; 11(1):e0146618. PubMed ID: 26783755
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of NANOG by YBX1 promotes lung cancer stem-like properties and metastasis.
Guo T; Kong J; Liu Y; Li Z; Xia J; Zhang Y; Zhao S; Li F; Li J; Gu C
Biochem Biophys Res Commun; 2017 May; 487(1):153-159. PubMed ID: 28400280
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
Eberle M; Ebel P; Mayer CA; Barthelmes J; Tafferner N; Ferreiros N; Ulshöfer T; Henke M; Foerch C; de Bazo AM; Grösch S; Geisslinger G; Willecke K; Schiffmann S
Immunol Cell Biol; 2015 Oct; 93(9):825-36. PubMed ID: 25833068
[TBL] [Abstract][Full Text] [Related]
14. CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress.
Fekry B; Jeffries KA; Esmaeilniakooshkghazi A; Ogretmen B; Krupenko SA; Krupenko NI
J Biol Chem; 2016 Aug; 291(32):16586-96. PubMed ID: 27302066
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1.
Deng X; Xiong W; Jiang X; Zhang S; Li Z; Zhou Y; Xiang B; Zhou M; Li X; Li G; Zeng Z; Gong Z
Cell Death Dis; 2020 Nov; 11(11):945. PubMed ID: 33144579
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia.
Verlekar D; Wei SJ; Cho H; Yang S; Kang MH
Cell Death Dis; 2018 Sep; 9(9):925. PubMed ID: 30206207
[TBL] [Abstract][Full Text] [Related]
17. Folate stress induces apoptosis via p53-dependent de novo ceramide synthesis and up-regulation of ceramide synthase 6.
Hoeferlin LA; Fekry B; Ogretmen B; Krupenko SA; Krupenko NI
J Biol Chem; 2013 May; 288(18):12880-90. PubMed ID: 23519469
[TBL] [Abstract][Full Text] [Related]
18. Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.
Fu L; Yang M; Ma Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):62-68. PubMed ID: 38279484
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
[TBL] [Abstract][Full Text] [Related]
20. Loss of CDH1 up-regulates epidermal growth factor receptor via phosphorylation of YBX1 in non-small cell lung cancer cells.
Liu X; Su L; Liu X
FEBS Lett; 2013 Dec; 587(24):3995-4000. PubMed ID: 24211838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
